AACR 2026: vídeos e entrevistas
32 vídeos do AACR 2026 publicados por AACR, Targeted Oncology, VJOncology. Atualizado em 20/11/2026.
Cancer Research Meets Artificial Intelligence: The Road to Revolutionized ResearchAACR · 09/11/2026 · 4:41
Dr Lyudmila Bazhenova: FDA Taletrectinib Label Update in ROS1+ NSCLCTargeted Oncology · 20/10/2026 · 7:01 · apoio da indústria
ROS1+ NSCLC: Key Takeaways From Case-Based Roundtables With Dr SantosTargeted Oncology · 14/07/2026 · 11:18 · apoio da indústria
Phase I trial of ABBV-368 tilsotolimod, budigalimab & nab-paclitaxel in HNSCCVJOncology · 06/05/2026 · 3:06 · apoio da indústria
Circulating HPV DNA to guide treatment adaptation in head & neck cancerVJOncology · 06/05/2026 · 3:03 · apoio da indústria
HPV head and neck cancer subtypes guide radiation and novel therapiesVJOncology · 06/05/2026 · 1:20 · apoio da indústria
Molecular subtypes of HPV-associated head and neck cancer and prognosisVJOncology · 06/05/2026 · 2:00 · apoio da indústria
Circulating HPV DNA in surveillance & MRD-guided head & neck cancer careVJOncology · 06/05/2026 · 3:46 · apoio da indústria
What does the future hold for cancer vaccines in the solid tumor space?VJOncology · 06/05/2026 · 1:34 · apoio da indústria
mRNA-4359 and pembrolizumab shows activity in advanced melanomaVJOncology · 06/05/2026 · 2:26 · apoio da indústria
Circulating HPV DNA in surveillance and MRD-guided head & neck cancer careVJOncology · 06/05/2026 · 1:35 · apoio da indústria
Liquid biopsy and ctDNA to guide treatment in head & neck cancerVJOncology · 06/05/2026 · 4:16 · apoio da indústria
Oncology highlights from AACR 2026VJOncology · 01/05/2026 · 17:42 · apoio da indústria
Elisrasib shows durable activity in pretreated KRAS G12C-mutant NSCLCVJOncology · 28/04/2026 · 3:30 · apoio da indústria
The future of anti-CCR8 antibodies in solid tumor oncologyVJOncology · 28/04/2026 · 1:22 · apoio da indústria
Phase I trial of denikitug, an anti-CCR8 antibody, in advanced solid tumorsVJOncology · 28/04/2026 · 3:44 · apoio da indústria
Zedoresertib and lunresertib shows activity in genomically altered tumorsVJOncology · 24/04/2026 · 9:56 · apoio da indústria
PLN-101095 shows promise in immune checkpoint inhibitor-resistant tumorsVJOncology · 24/04/2026 · 6:18 · apoio da indústria
Advancing research in immune-related adverse events in solid tumorsVJOncology · 24/04/2026 · 5:23 · apoio da indústria
Checkpoint irAEs: immune cell origins and treatment strategiesVJOncology · 24/04/2026 · 4:09 · apoio da indústria
Current and upcoming clinical biomarkers for head and neck cancerVJOncology · 24/04/2026 · 3:00 · apoio da indústria
Challenges & emerging therapies in HPV-independent head & neck cancerVJOncology · 24/04/2026 · 6:33 · apoio da indústria
Early detection strategies for HCC in metabolic disease populationsVJOncology · 21/04/2026 · 1:49 · apoio da indústria
Identifying responders to first-line therapy in advanced HCCVJOncology · 21/04/2026 · 3:23 · apoio da indústria
Using AI to predict liver decompensation risk in HCC with cirrhosisVJOncology · 21/04/2026 · 3:47 · apoio da indústria
Watch-and-wait after HER2 therapy in rectal cancer: benefits and risksVJOncology · 21/04/2026 · 2:24 · apoio da indústria
HER2 amplification predicts response in rectal cancer studiesVJOncology · 21/04/2026 · 3:05 · apoio da indústria
HER2 amplification predicts response in a Phase II rectal cancer studyVJOncology · 21/04/2026 · 5:04 · apoio da indústria
Biomarkers and AI approaches to improve lung cancer screening accuracyVJOncology · 21/04/2026 · 2:26 · apoio da indústria
Genomic drivers and targeted therapy in smoking-related lung cancerVJOncology · 21/04/2026 · 1:54 · apoio da indústria
Sherlock-Lung study reveals genomic drivers in never-smoker lung cancerVJOncology · 21/04/2026 · 2:26 · apoio da indústria
AACR Annual Meeting 2026: An Overview From the ChairsAACR · 12/03/2026 · 5:10